These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 866497)

  • 21. [Phenytoin kinetics in toxic serum levels].
    Beier R; Zschiesche M; Franke G
    Psychiatr Neurol Med Psychol (Leipz); 1983 Aug; 35(8):471-8. PubMed ID: 6635035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Serum diphenylhydantoin in epileptic patients (preliminary report)].
    Radzikowska B; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1977; 11(5):551-4. PubMed ID: 593505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population.
    Leppik IE
    Epilepsy Res Suppl; 1988; 1():85-90. PubMed ID: 3149581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical seizures in phenytoin toxicity.
    Chua HC; Venketasubramanian N; Tan CB; Tjia H
    Singapore Med J; 1999 Apr; 40(4):276-7. PubMed ID: 10487084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of increased bioavailability of phenytoin tablets on serum phenytoin concentration in epileptic out-patients.
    Neuvonen PJ; Bardy A; Lehtovaara R
    Br J Clin Pharmacol; 1979 Jul; 8(1):37-41. PubMed ID: 552295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood levels of phenytoin. Pharmacokinetics and individualization of dosages in controlled children with crises and with persistence of crises].
    García-Márquez F; Rodríguez-Blancas MC; Juárez-Olguín H; Díaz-López B; Ruiz-Chávez J
    Bol Med Hosp Infant Mex; 1990 Oct; 47(10):682-8. PubMed ID: 2278644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum phenytoin levels with different brands.
    Kishore K; Jailakhani BL; Sharma JN; Ahuja GK
    Indian J Physiol Pharmacol; 1986; 30(2):171-6. PubMed ID: 3546122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Investigations of serum levels of drugs in children receiving anticonvulsant medication. I. General evaluation of serum concentrations of diphenylhydantoin, primidone and phenobarbitone (author's transl)].
    Windorfer A; Gädeke R; Sauer M
    Z Kinderheilkd; 1975; 119(1):15-24. PubMed ID: 1124582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenytoin dosage requirements and pharmacokinetic variables.
    Taylor JW; Murphy MJ; Berg MJ; Perry PJ; Lyon LW; Ludden TM
    Clin Pharm; 1983; 2(3):253-7. PubMed ID: 6883953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum IgA, IgG, and IgM concentrations in patients with epilepsy and matched controls: a cohort-based cross-sectional study.
    Ranua J; Luoma K; Auvinen A; Peltola J; Haapala AM; Raitanen J; Isojärvi J
    Epilepsy Behav; 2005 Mar; 6(2):191-5. PubMed ID: 15710303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ethnic differences in serum phenytoin levels].
    Dam M; Hübbe P; Christiansen J
    Ugeskr Laeger; 1974 Aug; 136(35):1974-6. PubMed ID: 4848674
    [No Abstract]   [Full Text] [Related]  

  • 33. [Anti epileptic therapy with diphenylhydantoin with serum controls in childhood. Clinical experiences].
    Nolte R; Brügmann G; Besch W
    Bibl Psychiatr; 1975; (151):43-8. PubMed ID: 1156347
    [No Abstract]   [Full Text] [Related]  

  • 34. Systematic determination of the serum phenytoin level as an aid in the management of children with epilepsy.
    Norell E; Lilienberg G; Gamstorp I
    Eur Neurol; 1975; 13(3):232-44. PubMed ID: 807479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum-phenytoin levels in management of epilepsy.
    Richens A; Dunlop A
    Lancet; 1975 Aug; 2(7928):247-8. PubMed ID: 49797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenytoin ("dilantin") and fits.
    Bharucha EP
    J Assoc Physicians India; 1979 Feb; 27(2):154-6. PubMed ID: 511832
    [No Abstract]   [Full Text] [Related]  

  • 37. Letter: Serum-phenytoin and body-weight.
    Ayers GJ; Goudie JH; Burnett D
    Lancet; 1976 Apr; 1(7963):809-10. PubMed ID: 56625
    [No Abstract]   [Full Text] [Related]  

  • 38. Control of epilepsy with a single daily dose of phenytoin sodium.
    Cocks DA; Critchley EM
    Br J Clin Pharmacol; 1975 Oct; 2(5):449-53. PubMed ID: 786358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a delayed-action phenytoin preparation on blood phenytoin concentration.
    Bochner F; Hooper WD; Tyrer JH; Eadie MJ
    J Neurol Neurosurg Psychiatry; 1972 Oct; 35(5):682-4. PubMed ID: 5084136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma concentrations of 5-(4-hydroxyphenyl)-5-phenylhydantoin in phenytoin-treated patients.
    Hoppel C; Garle M; Rane A; Sjöqvist F
    Clin Pharmacol Ther; 1977 Mar; 21(3):294-300. PubMed ID: 837648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.